# Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis

> **NCT02914132** · NA · COMPLETED · sponsor: **ExThera Medical Corporation** · enrollment: 15 (actual)

## Conditions studied

- Bacteremia
- Bacterial Infection

## Interventions

- **DEVICE:** Seraph 100 Filter

## Key facts

- **NCT ID:** NCT02914132
- **Lead sponsor:** ExThera Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2018-06-07
- **Final completion:** 2018-06-07
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2019-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02914132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02914132, "Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02914132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*